Chronic Obstructive Pulmonary Disease

Coming Soon

Anti-IL5 Therapy Cuts Severe COPD Exacerbations - European Medical Journal [Visit Site | Read More]

Modeled reductions in COPD exacerbation rates, mortality, and related medical costs due to increased SITT adoption: PROMETHEUS Italy - BioMed Central [Visit Site | Read More]

GSK and Empirico enter license agreement for clinical-stage, first-in-class oligonucleotide candidate to treat respiratory diseases - GSK [Visit Site | Read More]

Treatment of chronic obstructive pulmonary disease: current pipeline and new opportunities - Nature [Visit Site | Read More]

Focusing on education, action for this year’s COPD Awareness Month - COPD News Today [Visit Site | Read More]